-
Nivolumab found to enhance survival rates among Kidney Cancer patients
In an important breakthrough achieved by medicinal sciences, Nivolumab has been found to extend the survival rates of patients with renal cancer. This may come as a huge wave of respite for many suffering from kidney cancer, which is one of the top 10 cancers of the human body, and which affects both men and […]